The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Body weight cycling in type 1 diabetes is associated with increased risk of chronic kidney disease. Maintaining stable weight ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Yo-Yo Dieting May Significantly Increase Kidney Disease Risk in People With Type 1 Diabetes Feb. 4 ... New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers ...

A retrospective cohort study found that sodium-glucose cotransporter 2 inhibitors were associated with a reduced risk of chronic kidney disease (CKD) in adults with type 2 diabetes. A ...

Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

Diabetes India has announced a nationwide campaign for early detection of Chronic Kidney Disease (CKD) in diabetes patients.

Although chronic diseases affect people of all ages, older adults are more vulnerable to them. In particular, certain ailments like heart disease, Type 2 diabetes, kidney disease, and some cancers ...